Predictive and Impact of Pain After 6 Months of Radiotherapy, in Head and Neck Cancer

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 13, 2023

Primary Completion Date

March 1, 2026

Study Completion Date

September 1, 2026

Conditions
Neuropathic PainAnxiety Disorder/Anxiety StatePain, ChronicAlcohol Use DisorderPsychoactive Substance UseSleepSymptoms and SignsAddiction Nicotine
Interventions
OTHER

Questionnaire

"Self-questionnaires are completed by the patient at the time of this consultation:~* Neuropathic pain: NPSI in screening~* Anxiety/depression: HADS in screening~* Quality of life: EORTC (QLQC30 and H\&N43)~* Fatigue: MFI-20 hese self-questionnaires will be retrieved by the Clinical Research Associate (CRA) for verification.~Depending on the result of the NPSI questionnaire can be completed to better characterize neuropathic pain.~Depending on the result of the HADS, the MADRS questionnaire can be completed to quantify the degree of depression.~Individuals diagnosed with neuropathic pain or other depressive symptoms during the 6-month inclusion period will be referred to and managed by specialized practitioners. This assistance will be indicated in follow-up report"

Trial Locations (1)

Unknown

RECRUITING

Caen University Hospital, Caen

All Listed Sponsors
collaborator

Centre Francois Baclesse

OTHER

lead

University Hospital, Caen

OTHER